{
    "clinical_study": {
        "@rank": "8293", 
        "arm_group": [
            {
                "arm_group_label": "Group A (avatrombopag, lower baseline platelet count)", 
                "arm_group_type": "Experimental", 
                "description": "60 mg avatrombopag (3 x 20 mg tablets) once daily on Days 1 through 5"
            }, 
            {
                "arm_group_label": "Group B (placebo, lower baseline platelet count)", 
                "arm_group_type": "Placebo Comparator", 
                "description": "placebo (3 x 20 mg matching placebo tablets) once daily on Days 1 through 5"
            }, 
            {
                "arm_group_label": "Group C (avatrombopag, higher baseline platelet count)", 
                "arm_group_type": "Experimental", 
                "description": "40 mg avatrombopag (2 x 20 mg tablets) once daily on Days 1 through 5"
            }, 
            {
                "arm_group_label": "Group D (placebo, higher baseline platelet count)", 
                "arm_group_type": "Placebo Comparator", 
                "description": "placebo (2 x 20 mg matching placebo tablets) once daily on Days 1 through 5"
            }
        ], 
        "brief_summary": {
            "textblock": "This is a global, multicenter, randomized, double-blind, placebo-controlled, parallel group\n      study using avatrombopag to treat adults with thrombocytopenia associated with liver\n      disease. The study will evaluate avatrombopag in the treatment of thrombocytopenia\n      associated with liver disease prior to an elective procedure to reduce the need for platelet\n      transfusions or any rescue procedure for bleeding due to procedural and post-procedural\n      bleeding complications. Subjects will be enrolled into 2 cohorts according to mean baseline\n      platelet count and, within each baseline platelet count cohort will be further stratified by\n      risk of bleeding associated with the elective procedure (low, moderate, or high) and\n      hepatocellular carcinoma (HCC) status (Yes or No)."
        }, 
        "brief_title": "Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure", 
        "completion_date": {
            "#text": "August 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Thrombocytopenia Associated With Liver Disease", 
        "condition_browse": {
            "mesh_term": [
                "Liver Diseases", 
                "Thrombocytopenia"
            ]
        }, 
        "detailed_description": {
            "textblock": "This study will consist of 3 phases: Prerandomization, Randomization, and a Follow-up Phase.\n      The Prerandomization Phase includes one Screening Visit that will take place from Day -14\n      through Day -1; the Randomization Phase includes the Baseline Period, Treatment Period, and\n      Procedure Day Period (5 to 8 days after last dose of study drug [Study Day 10 to 13]). The\n      Follow-up Phase comprises 2 visits: 7 days post Procedure Day and 30 days after receiving\n      the last dose of study drug.  Permitted procedures include: Dental procedures; Paracentesis;\n      Gastrointestinal endoscopy with or without plans for biopsy, colonoscopy, polypectomy, or\n      variceal banding; Liver biopsy; Bronchoscopy with or without plans for biopsy; Ablation\n      therapy (radiofrequency ablation or ethanol ablation) or chemoembolization for HCC; Vascular\n      catheterization and Transjugular intrahepatic portosystemic shunt."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n          1. Subjects greater than or equal to 18 years of age at Screening with chronic liver\n             disease\n\n          2. Subjects who have a mean baseline platelet count of less than 50 x 109/L. Platelet\n             counts must be measured on 2 separate occasions, during the Screening Period and at\n             Baseline, and must be performed at least one day apart with neither platelet count\n             greater than 60 x 109/L. The mean of these 2 platelet counts (mean baseline platelet\n             count) will be used for entry criteria and for assignment to the low or high baseline\n             platelet count cohort.\n\n          3. Subjects scheduled to undergo a permitted elective procedure who, in the opinion of\n             the investigator, will require a platelet transfusion to address a risk of bleeding\n             associated with the procedure\n\n          4. Model For End-stage Liver Disease (MELD) score less than or equal to 24 at Screening\n\n          5. If taking inhibitors of P glycoprotein (P-gp), except for verapamil, dose must be\n             stable for 7 days prior to Screening\n\n          6. Provide written informed consent\n\n          7. Willing and able to comply with all aspects of the protocol\n\n        Exclusion Criteria\n\n          1. Any history of arterial or venous thrombosis, including partial or complete\n             thrombosis\n\n          2. Evidence of thrombosis (partial or complete) in the main portal vein, portal vein\n             branches, or any part of the splenic mesenteric system at Screening\n\n          3. Adequate portal vein blood flow at Screening\n\n          4. Hepatic encephalopathy that cannot be effectively treated\n\n          5. Subjects with HCC with Barcelona Clinic Liver Cancer (BCLC) staging classification C\n             or D\n\n          6. Platelet transfusion or receipt of blood products containing platelets within 7 days\n             of Screening. However packed red blood cells are permitted.\n\n          7. Heparin, warfarin, nonsteroidal anti-inflammatory drugs (NSAID), aspirin, verapamil,\n             and antiplatelet therapy with ticlopidine or glycoprotein IIb/IIIa antagonists (eg,\n             tirofiban) within 7 days of Screening\n\n          8. Use of erythropoietin stimulating agents within 7 days of Screening\n\n          9. Interferon (IFN) use within 14 days of Screening\n\n         10. Estrogen-containing hormonal contraceptive or hormone replacement therapy use within\n             30 days of Screening\n\n         11. Active infection requiring systemic antibiotic therapy within 7 days of Screening.\n             However, prophylactic use of antibiotics is permitted.\n\n         12. Alcohol abuse, alcohol dependence syndrome, drug abuse, or drug dependence within 6\n             months of the study start (unless participating in a controlled rehabilitation\n             program) or acute alcoholic hepatitis (chronic alcoholic hepatitis is allowed) within\n             6 months of the study start\n\n         13. Elective procedure performed prior to Visit 4 (Procedure Day)\n\n         14. Known to be human immunodeficiency virus positive\n\n         15. Any clinically significant acute or active bleeding (eg, gastrointestinal, central\n             nervous system)\n\n         16. Known history of any primary hematologic disorder (eg, immune thrombocytopenic\n             purpura, myelodysplastic syndrome)\n\n         17. Known medical history of genetic prothrombotic syndromes\n\n         18. Subjects with a history of significant cardiovascular disease (eg, congestive heart\n             failure New York Heart Association Grade III/IV, arrhythmia known to increase the\n             risk of thromboembolic events [eg, atrial fibrillation], coronary artery stent\n             placement, angioplasty, and coronary artery bypass grafting)\n\n         19. Females of childbearing potential who have had unprotected sexual intercourse within\n             30 days before study entry and who do not agree to use a highly effective method of\n             contraception (eg, total abstinence, an intrauterine device, a double-barrier method\n             [such as condom plus diaphragm with spermicide], a progesterone-only contraceptive\n             implant/injection, or have a vasectomized partner with confirmed azoospermia)\n             throughout the entire study period and for 30 days after study drug discontinuation.\n             If currently abstinent, the subject must agree to use a double-barrier method as\n             described above if she becomes sexually active during the study period or for 30 days\n             after study drug discontinuation. All females will be considered to be of\n             childbearing potential unless they are postmenopausal (at least 12 months consecutive\n             amenorrhea in the appropriate age group and without other known or suspected cause)\n             or have been sterilized surgically (ie, bilateral tubal ligation, hysterectomy, or\n             bilateral oophorectomy) at least 1 month before dosing.\n\n         20. Females who are lactating or pregnant at Screening or Baseline (as documented by a\n             positive serum beta-human chorionic gonadotropin [B-hCG] test with a minimum\n             sensitivity 25 IU/L or equivalent units of B-hCG). A separate baseline assessment is\n             required if a negative screening pregnancy test was obtained more than 72 hours\n             before the first dose of study drug.\n\n         21. Post liver transplant subjects\n\n         22. Any subject who has previously received avatrombopag\n\n         23. Hypersensitivity to avatrombopag maleate or any of its excipients\n\n         24. Hemoglobin levels less than or equal to 8.0 or greater than or equal to 16.0 g/dL at\n             Screening\n\n         25. White blood cell count less than or equal to 1.5 x 10^9/L or greater than or equal to\n             15.0 x 10^9/L at Screening\n\n         26. Serum sodium level less than or equal to 130 mEq/L at Screening\n\n         27. Current malignancy including solid tumors and hematologic malignancies (except HCC)\n\n         28. Any history of or concomitant medical condition that, in the opinion of the\n             investigator(s), would compromise the subject's ability to safely complete the study\n\n         29. Currently enrolled in another clinical trial or used any investigational drug or\n             device within 30 days of Screening"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "300", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 24, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01976104", 
            "org_study_id": "E5501-G000-311", 
            "secondary_id": "2013-000934-36"
        }, 
        "intervention": [
            {
                "arm_group_label": "Group A (avatrombopag, lower baseline platelet count)", 
                "description": "60 mg avatrombopag (3 x 20 mg tablets)", 
                "intervention_name": "avatrombopag (lower baseline platelet count)", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Group B (placebo, lower baseline platelet count)", 
                "description": "60 mg placebo (3 x 20 mg matching placebo tablets)", 
                "intervention_name": "placebo (lower baseline platlet count)", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Group C (avatrombopag, higher baseline platelet count)", 
                "description": "40 mg avatrombopag (2 x 20 mg tablets)", 
                "intervention_name": "avatrombopag (higer baseline platelet count)", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Group D (placebo, higher baseline platelet count)", 
                "description": "40 mg placebo (2 x 20 mg matching placebo tablets)", 
                "intervention_name": "placebo (higher baseline platelet count)", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Thrombocytopenia", 
            "Chronic Liver Disease"
        ], 
        "lastchanged_date": "June 4, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Phoenix", 
                        "country": "United States", 
                        "state": "Arizona"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Coronado", 
                        "country": "United States", 
                        "state": "California"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Denver", 
                        "country": "United States", 
                        "state": "Colorado"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Orleans", 
                        "country": "United States", 
                        "state": "Louisiana"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Baltimore", 
                        "country": "United States", 
                        "state": "Maryland"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Detroit", 
                        "country": "United States", 
                        "state": "Michigan"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kansas City", 
                        "country": "United States", 
                        "state": "Missouri"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Charleston", 
                        "country": "United States", 
                        "state": "South Carolina"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dallas", 
                        "country": "United States", 
                        "state": "Texas"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Antonio", 
                        "country": "United States", 
                        "state": "Texas"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seattle", 
                        "country": "United States", 
                        "state": "Washington"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rosario", 
                        "country": "Argentina", 
                        "state": "Santa Fe"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ciudad Autonoma Buenos Aires", 
                        "country": "Argentina"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cordoba", 
                        "country": "Argentina"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Clayton", 
                        "country": "Australia", 
                        "state": "Victoria"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Heidelberg", 
                        "country": "Australia", 
                        "state": "Victoria"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Melbourne", 
                        "country": "Australia", 
                        "state": "Victoria"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Parkville", 
                        "country": "Australia", 
                        "state": "Victoria"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Edegem", 
                        "country": "Belgium"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Liege", 
                        "country": "Belgium"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Salvador", 
                        "country": "Brazil", 
                        "state": "Bahia"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Porto Alegre", 
                        "country": "Brazil", 
                        "state": "Rio Grande do Sul"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Botucatu", 
                        "country": "Brazil", 
                        "state": "Sao Paulo"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sao Paulo", 
                        "country": "Brazil"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Edmonton", 
                        "country": "Canada", 
                        "state": "Alberta"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brno", 
                        "country": "Czech Republic"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ostrava", 
                        "country": "Czech Republic"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Praha 4", 
                        "country": "Czech Republic"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Usti nad Labem", 
                        "country": "Czech Republic"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nice Cedex 3", 
                        "country": "France", 
                        "state": "Alpes Maritimes"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Clichy cedex", 
                        "country": "France", 
                        "state": "Hauts de Seine"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rennes cedex 09", 
                        "country": "France", 
                        "state": "Ille et Vilaine"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Creteil Cedex", 
                        "country": "France", 
                        "state": "Val de Marne"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Villejuif", 
                        "country": "France", 
                        "state": "Val de Marne"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Frankfurt", 
                        "country": "Germany", 
                        "state": "Hessen"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hannover", 
                        "country": "Germany", 
                        "state": "Niedersachsen"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bonn", 
                        "country": "Germany", 
                        "state": "Nordrhein Westfalen"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Leipzig", 
                        "country": "Germany", 
                        "state": "Sachsen"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Beer Yaakov", 
                        "country": "Israel"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Haifa", 
                        "country": "Israel"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Holon", 
                        "country": "Israel"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jerusalem", 
                        "country": "Israel"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Petach Tikva", 
                        "country": "Israel"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ramat-Gan", 
                        "country": "Israel"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rechovot", 
                        "country": "Israel"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Safed", 
                        "country": "Israel"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tel Aviv", 
                        "country": "Israel"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Firenze", 
                        "country": "Italy"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Milano", 
                        "country": "Italy"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pisa", 
                        "country": "Italy"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Roma", 
                        "country": "Italy"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Trento", 
                        "country": "Italy"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mexico", 
                        "country": "Mexico", 
                        "state": "Distrito Federal"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Monterrey", 
                        "country": "Mexico", 
                        "state": "Nuevo Leon"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Merida", 
                        "country": "Mexico", 
                        "state": "Yucatan"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Durango", 
                        "country": "Mexico"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Arad", 
                        "country": "Romania"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bucuresti", 
                        "country": "Romania"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Iasi", 
                        "country": "Romania"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sibiu", 
                        "country": "Romania"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Timisoara", 
                        "country": "Romania"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Moscow", 
                        "country": "Russian Federation"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Valencia", 
                        "country": "Spain"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Leeds", 
                        "country": "United Kingdom", 
                        "state": "West Yorkshire"
                    }
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Argentina", 
                "Australia", 
                "Belgium", 
                "Brazil", 
                "Canada", 
                "Czech Republic", 
                "France", 
                "Germany", 
                "Israel", 
                "Italy", 
                "Mexico", 
                "Romania", 
                "Russian Federation", 
                "Spain", 
                "United Kingdom"
            ]
        }, 
        "number_of_arms": "4", 
        "official_title": "A Randomized, Global, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Once-daily Oral Avatrombopag for the Treatment of Adults With Thrombocytopenia Associated With Liver Disease Prior to an Elective Procedure", 
        "overall_contact": {
            "last_name": "Eisai Medical Services", 
            "phone": "1-888-422-4743"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "European Union: European Medicines Agency", 
                "United States: Food and Drug Administration"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "To confirm that avatrombopag (60 mg avatrombopag for subjects with platelet count less than 40 x 10^9/L and 40 mg avatrombopag for subjects with platelet count from 40 to less than 50 x 10^9/L) is superior to placebo in removing the need for platelet transfusions or any rescue procedure for bleeding after randomization and up to 7 days following an elective procedure in subjects with chronic liver disease who have thrombocytopenia.", 
            "measure": "The proportion of subjects who require platelet transfusion or rescue therapy for bleed after randomization and up to 7 days after the elective procedure", 
            "safety_issue": "No", 
            "time_frame": "Baseline and up to 7 days after day of procedure"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01976104"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "To confirm that avatrombopag is superior to placebo in achieving a platelet count of greater than or equal to 50 x 109/L on Procedure Day in the proposed target population", 
                "measure": "Proportion of subjects who achieve a platelet counts greater than or equal to 50 x 10^9/L on Procedure day", 
                "safety_issue": "No", 
                "time_frame": "Day of Procedure"
            }, 
            {
                "description": "To confirm that avatrombopag is superior to placebo in elevating platelet counts from baseline on Procedure Day in the proposed target population", 
                "measure": "Change from baseline of platelet counts on procedure day", 
                "safety_issue": "No", 
                "time_frame": "Baseline and Day of Procedure"
            }, 
            {
                "description": "To evaluate whether the observed incidence of bleeding in subjects treated with avatrombopag is noninferior to placebo in those subjects expected to receive a platelet transfusion prior to their procedure", 
                "measure": "Proportion of subjects with a WHO bleeding score greater than or equal to 2 after randomization and up to 7 days after an elective procedure", 
                "safety_issue": "No", 
                "time_frame": "Baseline and up to 7 days after day of procedure"
            }, 
            {
                "description": "Safety assessments will consist of monitoring and recording of all adverse events (AEs) and serious adverse events (SAEs), including platelet transfusion-related complications; routine laboratory evaluations.  At selected sites, platelet function will also be measured using specified flow cytometric markers.", 
                "measure": "Safety of avatrombopag", 
                "safety_issue": "Yes", 
                "time_frame": "Up to 20 months"
            }
        ], 
        "source": "Eisai Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Eisai Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2014"
    }
}